Search

everythinglearnresearchcommunity

for

Search:↓

The ABCG2 gene variant increases the risk of high uric acid and cholesterol, especially in overweight or obese young Mexican males.

Hibiscus syriacus L. flower extracts may help lower blood sugar and improve cholesterol in diabetes.

Amalaki improves cholesterol, blood sugar, inflammation, and liver function without serious side effects.

Amalaki improves health in many areas, including cholesterol, blood sugar, and liver function, with no serious side effects.

Baricitinib effectively treated alopecia areata in 73% of patients, with minor metabolic changes and significant changes in inflammatory markers.

Women aged 21-26 have a higher rate of PCOS.

Higher levels of molybdenum and lead in hair are linked to increased cholesterol and dyslipidemia risk.

Baricitinib slightly increased cholesterol levels in alopecia areata patients, but these changes were manageable.

PCOS women have more arm fat and higher insulin resistance and glucose levels than non-PCOS women.

Men and women respond differently to drugs for COVID-19, high cholesterol, and diabetes, which suggests a need for personalized treatments.

Type 3 acromegaly patients have more health issues and higher death risk.

Type 2 diabetes in youth is increasing, with high treatment failure rates and more severe than Type 1; certain drugs can lower lipid levels effectively with varying side effects, and apples may benefit heart health like statins but with fewer side effects.

Exposure to certain sex hormones can increase health risks, while some hormone therapies may offer benefits for specific conditions.

Stress and hormones like progesterone can affect absence seizures, but their effects change with different life stages.

Targeting LPA could help treat skin disorders.

Phospholipases help maintain and restore skin and hair health, potentially leading to new treatments for related conditions.

Lysophosphatidic acid is important for skin health and disease, and could be a target for new skin disorder treatments.

Phosphatide distribution in mouse skin remains consistent in both normal and cancerous growths.

Lysophospholipids can act as anti-inflammatory agents through specific receptors, but more research is needed.

LPA3 is crucial for embryo implantation and links LPA to prostaglandin signaling.

Not having the gene PLAAT3 leads to fat loss, high insulin resistance, and abnormal fat levels in the blood due to a disruption in fat cell development and function.

Phospholipase A2 enzymes play key roles in skin health and disease.

L-PGDS has specific binding sites for its functions and could help in drug delivery system design.

New LPA receptors (LPA4, LPA5, LPA6) have diverse roles in the body.

Lysophospholipids like LPA and S1P are important for hair growth, immune responses, and vascular development, and could be targeted for treating diseases.

People with atopic dermatitis have more CD4+ T cells that respond to a certain bacterial lipid, which may play a role in the skin condition's inflammation.

Lead can help reveal and organize lipids in human hair.

LPAR6 has a unique way of binding and activating, which helps in designing treatments for hair loss and cancer.

Lecithin organogels could be good for applying drugs to the skin because they are stable, safe, and can improve drug absorption.